Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2010
09/23/2010WO2010033424A3 Nutritional support of the immune system during anti-cancer treatment
09/23/2010WO2010020767A3 Glp-1 fusion polypeptides
09/23/2010WO2009142773A4 Multivalent fibronectin based scaffold domain proteins
09/23/2010WO2009114869A3 Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis
09/23/2010WO2009097332A3 Therapeutic compositions comprising an amine-containing lipid and a protein
09/23/2010WO2009065897A3 Inhibitors of malt1 proteolytic activity and uses thereof
09/23/2010US20100241059 Method and portable device for treating skin disorders
09/23/2010US20100240876 Replikins and methods of identifying replikin-containing sequences
09/23/2010US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells
09/23/2010US20100240866 Modified gherlin peptides
09/23/2010US20100240742 Anti-angiogenic compositions and methods of use
09/23/2010US20100240735 Pharmaceutical Compositions for Angiogenic Therapy
09/23/2010US20100240638 Organic Compounds and their uses
09/23/2010US20100240599 Antioxidant constituents
09/23/2010US20100240598 Peptides and peptide mimetics to inhibit the onset and/or progression of fibrotic and/or pre-fibrotic pathologies
09/23/2010US20100240597 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
09/23/2010US20100240596 Repair of ruptured membrane by injection of naturally occurring protein in amniotic fluid sac
09/23/2010US20100240595 Improved Antitumoral Treatments
09/23/2010US20100240594 Targeted delivery of chemotherapeutic agents
09/23/2010US20100240593 Strontium-apatite cement preparation cements formed therefrom, and use thereof
09/23/2010US20100240592 Template-fixed peptidomimetics with antimicrobial activity
09/23/2010US20100240591 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
09/23/2010US20100240590 Peptides and related molecules that bind to tall-1
09/23/2010US20100240589 Diastereomeric peptides useful as inhibitors of membrane protein assembly
09/23/2010US20100240588 Compound for use in the treatment of peripheral neuropathies
09/23/2010US20100240587 Stable formulations of amylin and its analogues
09/23/2010US20100240586 Peg modified exendin or exendin analog and compositions and use thereof
09/23/2010US20100240585 In vivo cell surface engineering
09/23/2010US20100240584 Nematode-extracted serine protease inhibitors and anticoagulant proteins
09/23/2010US20100240583 Soluble protein and utilization of the same
09/23/2010US20100240582 Peptides and related molecules that modulate nerve growth factor activity
09/23/2010US20100240581 Selective proteasome inhibitors for treating diabetes
09/23/2010US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof
09/23/2010US20100240579 Detection of cell surface binding molecules using a phage display blocking assay
09/23/2010US20100240578 Anti-h5n1 influenza activity of the antiviral protein cyanovirin
09/23/2010US20100240577 Bacteriocins and Novel Bacterial Strains
09/23/2010US20100240576 Anticonvulsant combination therapy
09/23/2010US20100240575 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
09/23/2010US20100240574 Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor
09/23/2010US20100240145 Novel hemopoietin receptor protein, NR10
09/23/2010US20100240125 Bone delivery conjugates and method of using same to target proteins to bone
09/23/2010US20100240096 Novel hemopoietin receptor protein, nr10
09/23/2010US20100239691 Modulating latency and reactivation of mycobacterium tuberculosis
09/23/2010US20100239683 Sustained release of microcrystalline peptide suspensions
09/23/2010US20100239682 Colonic delivery of antimicrobial agents
09/23/2010US20100239676 Stable Aerosolizable Suspensions of Proteins in Ethanol
09/23/2010US20100239666 Process for producing mouldings from (meth) acrylate copolymers by means of injection moulding
09/23/2010US20100239663 Composition for foodstuff for binding acetaldehyde
09/23/2010US20100239657 Composite for liver-specific delivery and release of therapeutic nucleic acids or drugs
09/23/2010US20100239654 Vesicular phospholipid gels comprising proteinaceous substances
09/23/2010US20100239653 Pharmaceutical preparations and methods for inhibiting tumors
09/23/2010US20100239649 Tumor Suppressor Factor
09/23/2010US20100239635 Drug delivery medical device
09/23/2010US20100239634 Compositions and methods for promoting bone formation
09/23/2010US20100239615 Compositions and methods for the therapy and diagnosis of lung cancer
09/23/2010US20100239608 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
09/23/2010US20100239596 Grp78 and tumor angiogenesis
09/23/2010US20100239592 Methods of analysis and detecting molecular defects in transcobalamin i deficiency
09/23/2010US20100239587 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
09/23/2010US20100239586 Procalin polypeptides, antigens, and methods of use
09/23/2010US20100239581 Kidney disease targets and uses thereof
09/23/2010US20100239578 Modulation of sirp-alpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
09/23/2010US20100239574 High potency recombinant antibodies and method for producing them
09/23/2010US20100239566 Enigma-mdm2 interaction and uses thereof
09/23/2010US20100239565 Methods of treatment of skin ulcers
09/23/2010US20100239564 Novel human growth factors
09/23/2010US20100239562 Kv CHANNELS IN NEURODEGENERATION AND NEUROPROTECTION
09/23/2010US20100239560 Multi component non-woven
09/23/2010US20100239559 Novel nutritional food products for improved digestion and intestinal absorption
09/23/2010US20100239558 Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases
09/23/2010US20100239557 Compositions and methods of using chondroitinase abci mutants
09/23/2010US20100239556 Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system
09/23/2010US20100239554 Extended recombinant polypeptides and compositions comprising same
09/23/2010US20100239553 Methods for promoting cellular health and treatment of cancer
09/23/2010US20100239551 Compounds and compositions as channel activating protease inhibitors
09/23/2010US20100239550 MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL
09/23/2010US20100239547 Synthetic hla binding peptide analogues and uses thereof
09/23/2010US20100239534 Hybrid proteins that migrate retrogradely and transynaptically into the CNS
09/23/2010US20100239532 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof
09/23/2010US20100239531 Stable liquid interferon formulations
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239529 PEG-Interferon-Beta Formulations
09/23/2010US20100239528 Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta
09/23/2010US20100239527 2,3-substituted azaindole derivatives for treating viral infections
09/23/2010US20100239526 Substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds
09/23/2010US20100239525 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
09/23/2010US20100239524 Microparticles prepared using an ionic liquid
09/23/2010US20100239523 Tlr modulators and methods for using the same
09/23/2010US20100239522 Chemotherapeutic for inducing an msh2-dependent apoptotic pathway
09/23/2010US20100239520 Organic compounds
09/23/2010US20100239517 Novel conjugated proteins and peptides
09/23/2010US20100239503 Calcium-binding agents induce hair growth and/or nail growth
09/23/2010US20100239497 Oxidized avidin with high residency time in the treated tissues
09/23/2010DE212008000064U1 Vorrichtung zur Überwachung der Diabetes-Insulin-Therapie Apparatus for monitoring the Diabetes Insulin therapy
09/23/2010DE202009017887U1 Verwendung einer Zusammensetzung umfassend Pflanzenlektin, proteolytisches Enzym und Selenverbindung zum Schleimhautschutz und Linderung anderer Symptome Use of a composition comprising plant lectin, proteolytic enzyme and selenium compound to mucosal protection and relief of other symptoms
09/23/2010CA2793800A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
09/23/2010CA2793683A1 Peptidomimetics for modulating interleukin-1 receptor
09/23/2010CA2755971A1 Crystalline tripeptide epoxy ketone protease inhibitors
09/23/2010CA2755786A1 Targets for growth factor signalling and methods of therapy
09/23/2010CA2755784A1 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
1 ... 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 ... 3163